Ultrasensitive assay of prostate-specific antigen for early detection of residual cancer after radical prostatectomy

International Journal of Urology

Volumn 5, Issue 6, 1998, Pages 550-555

  Arai, Yoichi ^a   Okubo, Kazutoshi ^a   Aoki, Yoshitaka ^a   Maekawa, Shinya ^a   Okada, Takashi ^a   Maeda, Hiroshi ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Ultrasensitive assay

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RECURRENCE; CLINICAL ARTICLE; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RELAPSE; TIME;

EID: 0032444685     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1998.tb00411.x     Document Type: Article

References (26)

1. Oesterling JE. Prostate specific antigen: a critical assessment of the most useful marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
2. Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 1993;39:181-195.
3. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R. The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 1989;141: 873-879.
4. Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358-1368.
5. Takayama TK, Vessella RL, Brawer MK, Noteboom J, Lange PH. The enhanced detection of persistent disease after prostatectomy with a new prostate specific antigen immunoassay. J Urol 1993;150:374-378.
6. Stamey TA, Graves HCB, Wehner N, Ferrari M, Freiha FS. Early detection of residual prostate cancer after radical prostatectomy by an ultrasensitive assay for prostate specific antigen. J Urol 1993;149:787-792.
7. Yu H, Diamandis EP, Prestigacomo AF, Stamey TA. Ultrasensitive assay of prostate-specific antigen used for early detection of prostate cancer relapse and estimation of tumor-doubling time after radical prostatectomy. Clin Chem 1995;41:430-434.
8. Vessella RL, Noteboom J, Lange PH. Evaluation of the automated Abbott IMx prostate specific antigen (PSA) immunoassay. Clin Chem 1992;38:2044-2054.
9. Prestigacomo AF, Stamey TA. Comparison of 4 ultrasensitive prostate specific antigen assays for early detection of residual cancer after radical prostatectomy. J Urol 1994;152:1515-1519.
10. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 1996;42:675-684.
11. Yu H, Diamandis P, Wong P, Nam R, Tachtenberg J. Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 μg/L. J Urol 1997; 157:913-918.
12. Witherspoon LR, Lapeyrolerie T. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol 1997;157:1322-1328.
13. Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Sobin LH, Wagner G. TNM Atlas. 3rd ed. 2nd version. Berlin: Springer-Verlag, 1992.
14. Gleason DF, Mellinger GT and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.
15. Egawa S, Suyama K, Ohori M, Kawakami T, Kuwano S, Hirokado K, Hirano S, Yokoyama E, Uchida T, Koshiba K. Early detection of prostate cancer. Results of a prostate specific antigen-based detection program in Japan. Cancer 1995;76:463-472.
16. Gann PH, Hennekens CH, Stampher MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA 1995;273:289-294.
17. Mione R, Barichello M, Sartorello P, Leon A, Barioli P, Gion M. Third-generation PSA: ultrasensitive or ultraprecise assay? Int J Biol Markers 1995;10:229-235.
18. Stamey TA. Second Stanford conference on international standardization of prostate-specific antigen immunoassays: September 1 and 2, 1994. Urology 1995;45:173-184.
19. Stamey TA. Some comments on progress in the standardization of immunoassays for prostate-specific antigen. Br J Urol 1997;79(suppl):49-52.
20. Schild SE, Wong WW, Novicki DE, Ferrigni RG, Swanson SK. Detection of residual prostate cancer after radical prostaectomy with the Abbott IMx PSA assay. Urology 1996; 47:878-881.
21. Liedtke RJ, Kroon G, Batjer JD. Modified assay of prostate-specific antigen with a detection limit < 0.01 μg/L. Clin Chem 1993;39:2150-2154.
22. Witherspoon LR. Early detection of cancer relapse after prostatectomy using very sensitive prostate-specific antigen measurements. Br J Urol 1997;79(suppl):82-86.
23. Kamoshida S, Tsutsumi Y. Extraprostatic localization of prostatic acid phosphatase and prostatic-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 1990;21:1108-1112.
24. Iwakiri J, Grandbois K, Graves HCB, StameyTA. An analysis of urinary prostate-specific antigen before and after radical prostatectomy: evidence for secretion of prostate-specific antigen by the periurethral glands. J Urol 1993; 149:783-786.
25. Graves HCB. Prostate-specific antigen comes of age in diagnosis and management of prostate cancer. Clin Chem 1992;38:1930-1932.
26. Thompson IM. Editorial: prostate cancer. J Urol 1997; 157:919-920.